Zacks Investment Management Adma Biologics, Inc. Transaction History
Zacks Investment Management
- $11.4 Billion
- Q3 2024
A detailed history of Zacks Investment Management transactions in Adma Biologics, Inc. stock. As of the latest transaction made, Zacks Investment Management holds 288,009 shares of ADMA stock, worth $4.87 Million. This represents 0.05% of its overall portfolio holdings.
Number of Shares
288,009Holding current value
$4.87 Million% of portfolio
0.05%Shares
2 transactions
Others Institutions Holding ADMA
# of Institutions
321Shares Held
189MCall Options Held
917KPut Options Held
91.6K-
Black Rock Inc. New York, NY18.6MShares$315 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA18.1MShares$306 Million0.01% of portfolio
-
State Street Corp Boston, MA13MShares$220 Million0.01% of portfolio
-
Invesco Ltd. Atlanta, GA12.6MShares$213 Million0.05% of portfolio
-
Morgan Stanley New York, NY8.6MShares$145 Million0.01% of portfolio
About ADMA BIOLOGICS, INC.
- Ticker ADMA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 196,356,992
- Market Cap $3.32B
- Description
- ADMA Biologics, Inc., a biopharmaceutical company, engages in developing, manufacturing, and marketing specialty plasma-derived biologics for the treatment of immune deficiencies and infectious diseases in the United States and internationally. It offers BIVIGAM, an intravenous immune globulin (IVIG) product indicated for the treatment of primar...